Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?"
Pharmacol Res. 2020 Aug:158:104933.
doi: 10.1016/j.phrs.2020.104933.
Epub 2020 May 20.
1 Ospedale di Macerata, Division of Dermatology, Via Santa Lucia 2, Macerata, 62100, Italy; Ospedale di Macerata, Division of Medicina COVID, Via Santa Lucia 2, Macerata, 62100, Italy. Electronic address: gabriele.gc24@gmail.com.
2 Ospedale di Macerata, Division of Medicina COVID, Via Santa Lucia 2, Macerata, 62100, Italy; Ospedale di Macerata, Division of Neurology, Via Santa Lucia 2, Macerata, 62100, Italy.
3 Ospedale di Macerata, Division of Medicina COVID, Via Santa Lucia 2, Macerata, 62100, Italy; Ospedale di Macerata, Division of Pneumology, Via Santa Lucia 2, Macerata, 62100, Italy.